G Protein-Coupled Receptors and their Signaling Pathways: Classical Therapeutical Targets Susceptible to Novel Therapeutic Concepts
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1937-1958
Author(s):
Claus Liebmann
Tumor Intracellular Redox Status and Drug Resistance-Serendipity or a Causal Relationship?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1969-1977
Author(s):
Shazib Pervaiz and Marie-Veronique Clement
SRC: Regulation, Role in Human Carcinogenesis and Pharmacological Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1745-1756
Author(s):
A. Y. Tsygankov and S. K. Shore
Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1767-1784
Author(s):
M. Cetkovic-Cvrlje and H. E. Tibbles
The HVJ-Envelope as an Innovative Vector System for Cardiovascular Disease
Journal:
Current Gene Therapy
Volume:
4
Page:
183-194
Author(s):
Hitoshi Kotani, Toshihiro Nakajima, Shoupeng Lai, Ryuichi Morishita and Yasufumi Kaneda
Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
327-336
Author(s):
Daniel Sliva
Blocking Ca2+ Entry: A Way to Control Cell Proliferation
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
1533-1543
Author(s):
Luca Munaron, Susanna Antoniotti, Alessandra Fiorio Pla and Davide Lovisolo
Trichostatin A - like Hydroxamate Histone Deacetylase Inhibitors as Therapeutic Agents: Toxicological Point of View
Journal:
Current Medicinal Chemistry
Volume:
11
Page:
1629-1643
Author(s):
Tamara Vanhaecke, Peggy Papeleu, Greetje Elaut and Vera Rogiers
Immunotoxins and Other Conjugates: Pre-clinical Studies
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
563-583
Author(s):
A. Bolognesi and L. Polito
Epidemiology of Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
121-128
Author(s):
Luigi Naldi